Search results
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now | The Motley Fool
The Motley Fool· 7 days agoDespite some turbulence, growth stocks have been on a bull run since the 2008 financial crisis....
HPV jab stops 90% of cancer cases & could eradicate disease 'in our lifetime'
The US Sun· 7 days agoTHE HPV jab is cutting cases of cervical cancer by 90 per cent, a new study has found. The study,...
New measles case reported in Philadelphia region
PhillyVoice.com· 2 days agoThursday, May 16, and 12:30 a.m. Friday, May 17, of possible exposure. Anyone who visited the Holy Redeemer Hospital's medical-surgical unit between...
24 Modern-Day Inventions That People Over 30 Would've Given Anything To Have Back In The Day (And...
BuzzFeed via Yahoo News· 2 days agoMaskot / Getty Images 12."I love the Flawless shavers! When I was a teen, I had a stache! There were...
Fed study offers new clues that help explain America’s gloomy mood
Yahoo Finance· 14 hours agoMost experts think these huge variations come from on-and-off COVID stimulus, including the child...
Chicago health officials warn of rise in meningococcal disease as CDC issues health advisory
NBC Chicago· 7 days agoChicago public health officials are warning about a rise in cases of meningococcal disease....
...Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and...
Centers for Disease Control and Prevention· 2 days agoInvasive Streptococcus pneumoniae infections can cause deadly diseases such as meningitis and bacteremia. In Denmark, children <2 years of age have been routinely vaccinated against pneumococcal ...
Sanofi (SNY) Signs Deal for AI-Powered Drug Development
Zacks via Yahoo Finance· 19 hours agoModerna is looking to integrate generative AI to advance its broad and diverse portfolio of mRNA...
Are new COVID variants — called ‘FLiRT’ — spreading in California? A UC doctor explains
The Sacramento Bee· 7 days agoAnd why are they being called “FLiRT”? Dr. Peter Chin-Hong at UC San Francisco breaks it down.
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 2 days agoThe efficacy of ARCT-154 against severe COVID-19 was 100 percent in healthy persons aged 18-59 and more than 90 percent in persons at risk of severe consequences of the disease due...